The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Protective Effects of IL-6 Blockade in Sepsis Are Linked to Reduced C5a Receptor Expression
Abstract
IL-6 is known to be an important pro- and anti-inflammatory cytokine, which is up-regulated during sepsis. Our previous work has suggested a role for IL-6 in the up-regulation of C5aR in sepsis. We reported earlier that interception of C5a or C5aR results in improved outcomes in experimental sepsis. Using the cecal ligation/puncture (CLP) model in mice, we now demonstrate that treatment with anti-IL-6 Ab (anti-IL-6) results in significantly improved survival, dependent on the amount of Ab infused. CLP animals showed significantly increased binding of 125I-labeled anti-C5aR to organs when compared to either control mice at 0 h or CLP animals infused with normal rabbit 125I-labeled IgG. Binding of 125I-labeled anti-C5aR to lung, liver, kidney, and heart was significantly decreased in anti-IL-6-treated animals 6 h after CLP. RT-PCR experiments with mRNA isolated from various organs obtained 3, 6, and 12 h after CLP demonstrated increased C5aR mRNA expression during the onset of sepsis, which was greatly suppressed in CLP mice treated with anti-IL-6. These data suggest that IL-6 plays an important role in the increased expression of C5aR in lung, liver, kidney, and heart during the development of sepsis in mice and that interception of IL-6 leads to reduced expression of C5aR and improved survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Starnes, H. F., Pearce, M. K., Tewari, A., Yim, J. H., Zou, J. C., & Abrams, J. S. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4185 · Cited by 322
RetractedHaine, M. M.-L., & Meeùs, N. (1986) · Cited by 3,464
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139 · cited 1×
“I nterleukin-6 is a 212-aa polypeptide (1) known to have a variety of biological effects.”
Impaired immune and acute-phase responses in interleukin-6-deficient mice
Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G. (1994) · Nature · doi:10.1038/368339a0 · Cited by 1,768 · cited 1×
“It has been reported that IL-6 knockout mice do not show improved survival in CLP-induced sepsis (39) and that they suffer from impaired immune and acute-phase responses (40).”
Gauldie, J., Richards, C., Harnish, D., Lansdorp, P., & Baumann, H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7251 · Cited by 1,635
Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., & Kishimoto, T. (1989) · Cell · doi:10.1016/0092-8674(89)90438-8 · Cited by 1,396
Interleukin-6 in Biology and Medicine
Akira, S., Taga, T., & Kishimoto, T. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60532-5 · Cited by 1,389
Waage, A., Brandtzaeg, P., Halstensen, A., Kierulf, P., & Espevik, T. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.1.333 · Cited by 1,173
Cloning and Expression of the Human Interleukin-6 (BSF-2/IFNβ 2) Receptor
Yamasaki, K., Taga, T., Hirata, Y., Yawata, H., Kawanishi, Y., Seed, B., Taniguchi, T., Hirano, T., & Kishimoto, T. (1988) · Science · doi:10.1126/science.3136546 · Cited by 1,060
Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome
Casey, L. C., Balk, R. A., & Bone, R. C. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-8-199310150-00001 · Cited by 1,041
Molecular cloning and expression of an IL-6 signal transducer, gp130
Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T., & Kishimoto, T. (1990) · Cell · doi:10.1016/0092-8674(90)90411-7 · Cited by 1,039
Increased plasma levels of interleukin-6 in sepsis [see comments]
Hack, C., De Groot, E., Felt-Bersma, R., Nuijens, J., Strack Van Schijndel, R., Eerenberg-Belmer, A., Thijs, L., & Aarden, L. (1989) · Blood · doi:10.1182/blood.v74.5.1704.1704 · Cited by 811
Cytokine Serum Level During Severe Sepsis in Human IL-6 as a Marker of Severity
DAMA, P., LEDOUX, D., NYS, M., VRINDTS, Y., GROOTE, D. D., FRANCHIMONT, P., & LAMY, M. (1992) · Annals of Surgery · doi:10.1097/00000658-199204000-00009 · Cited by 808
The chemotactic receptor for human C5a anaphylatoxin
Gerard, N. P., & Gerard, C. (1991) · Nature · doi:10.1038/349614a0 · Cited by 655
Remick, D. G., Newcomb, D. E., Bolgos, G. L., & Call, D. R. (2000) · Shock · doi:10.1097/00024382-200013020-00004 · Cited by 534
Calandra, T., Gerain, J., Heumann, D., Baumgartner, J.-D., & Glauser, M. P. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90069-a · Cited by 442
Protective effects of C5a blockade in sepsis
Czermak, B. J., Sarma, V., Pierson, C. L., Warner, R. L., Huber-Lang, M., Bless, N. M., Schmal, H., Friedl, H. P., & Ward, P. A. (1999) · Nature Medicine · doi:10.1038/10512 · Cited by 404
Self-citationInduction of rat acute‐phase proteins by interleukin 6 in vivo
Geiger, T., Andus, T., Klapproth, J., Hirano, T., Kishimoto, T., & Heinrich, P. C. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180510 · Cited by 403
van der Poll, T., Levi, M., Hack, C. E., ten Cate, H., van Deventer, S. J., Eerenberg, A. J., de Groot, E. R., Jansen, J., Gallati, H., & Büller, H. R. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1253 · Cited by 383
Eskandari, M. K., Bolgos, G., Miller, C., Nguyen, D. T., DeForge, L. E., & Remick, D. G. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.9.2724 · Cited by 323
Endotoxin, tumor necrosis factor-α and interleukin 1 induce interleukin 6 production in vivo
Shalaby, M. R., Waage, A., Aarden, L., & Espevik, T. (1989) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(89)90010-x · Cited by 294
Multiple forms of IFN-beta 2/IL-6 in serum and body fluids during acute bacterial infection.
Helfgott, D. C., Tatter, S. B., Santhanam, U., Clarick, R. H., Bhardwaj, N., May, L. T., & Sehgal, P. B. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.3.948 · Cited by 237
Role of IL-6 and TNF in thermoregulation and survival during sepsis in mice
Leon, L. R., White, A. A., & Kluger, M. J. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.275.1.r269 · Cited by 236
Role of C5a in Multiorgan Failure During Sepsis
Huber-Lang, M., Sarma, V. J., Lu, K. T., McGuire, S. R., Padgaonkar, V. A., Guo, R.-F., Younkin, E. M., Kunkel, R. G., Ding, J., Erickson, R., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.1193 · Cited by 224
Self-citationIncreased C5a receptor expression in sepsis
Riedemann, N. C., Guo, R., Neff, T. A., Laudes, I. J., Keller, K. A., Sarma, V. J., Markiewski, M. M., Mastellos, D. C., Strey, C. W., Pierson, C. L., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15409 · Cited by 190
Self-citationEndotoxin-induced shock in the rat. A role for C5a.
SMEDEGÅRD, G., Cui, L., & Hugli, T. E. (1989) · PubMed · Cited by 179
Characterization of a Receptor for C5a Anaphylatoxin on Human Eosinophils
Gerard, N. P., Hodges, M. K., Drazen, J. M., Weller, P. F., & Gerard, C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94252-3 · Cited by 164
Remick, D., Manohar, P., Bolgos, G., Rodriguez, J., Moldawer, L., & Wollenberg, G. (1995) · Shock · doi:10.1097/00024382-199508000-00002 · Cited by 164
Increased C5a receptor expression in sepsis
Riedemann, N. C., Guo, R., Neff, T. A., Laudes, I. J., Keller, K. A., Sarma, V. J., Markiewski, M. M., Mastellos, D. C., Strey, C. W., Pierson, C. L., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215409 · Cited by 157
Self-citationProtective effects of anti-C5a in sepsis-induced thymocyte apoptosis
Guo, R., Huber-Lang, M. S., Wang, X., Sarma, V. J., Padgaonkar, V. A., Craig, R. A., Riedemann, N. C., McClintock, S. D., Hlaing, T., Shi, M. M., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10793 · Cited by 152
Self-citationTransfection of Malaria Parasites
Waters, A. P., Thomas, A. W., van Dijk, M. R., & Janse, C. J. (1997) · Methods · doi:10.1006/meth.1997.0506 · Cited by 134
Protective effects of anti‐C5a peptide antibodies in experimental sepsis
Huber-Lang, M. S., Sarma, J. V., McGuire, S. R., Lu, K. T., Guo, R. F., Padgaonkar, V. A., Younkin, E. M., Laudes, I. J., Riedemann, N. C., Younger, J. G., et al. (2001) · The FASEB Journal · doi:10.1096/fj.00-0653fje · Cited by 133
Self-citationExpression and Function of the C5a Receptor in Rat Alveolar Epithelial Cells
Riedemann, N. C., Guo, R., Sarma, V. J., Laudes, I. J., Huber-Lang, M. S., Warner, R. L., Albrecht, E. A., Speyer, C. L., & Ward, P. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1919 · Cited by 104
Self-citationInterleukin-6 administration has no acute hemodynamic or hematologic effect in the dog
Preiser, J., Schmartz, D., der Linden, P. V., Content, J., Bussche, P. V., Buurman, W. A., Sebald, W., Dupont, É., Pinsky, M. R., & Vincent, J. (1991) · Cytokine · doi:10.1016/1043-4666(91)90002-u · Cited by 104
Heremans, H., Dillen, C., Put, W., Damme, J. V., & Billiau, A. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220932 · Cited by 101
C5a receptor and thymocyte apoptosis in sepsis
Riedemann, N. C., Guo, R., Laudes, I. J., Keller, K. A., Sarma, V. J., Padgaonkar, V. A., Zetoune, F. S., & Ward, P. A. (2002) · The FASEB Journal · doi:10.1096/fj.02-0033fje · Cited by 86
Self-citationLibert, C., Vink, A., Coulie, P. G., Brouckaert, P., Everaerdt, B., Snick, J. V., & Fiers, W. (1992) · European Journal of Immunology · doi:10.1002/eji.1830221023 · Cited by 81
Identification of the C3b receptor-binding domain in third component of complement.
Becherer, J. D., & Lambris, J. D. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68260-2 · Cited by 58
Self-citationSchieferdecker, H. L., Schlaf, G., Koleva, M., Götze, O., & Jungermann, K. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5453 · Cited by 43
Sheron, N., Lau, J. N., Hofmann, J. J., Williams, R., & Alexander, G. (1990) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1990.tb05465.x · Cited by 26
Cited by
Cytokine storm and sepsis disease pathogenesis
Chousterman, B. G., Swirski, F. K., & Weber, G. F. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0639-8 · Cited by 1,330
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
Jones, S. A., & Jenkins, B. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0066-7 · Cited by 1,102
Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome
Bhatia, M., & Moochhala, S. (2004) · The Journal of Pathology · doi:10.1002/path.1491 · Cited by 1,095
Cecal ligation and puncture: the gold standard model for polymicrobial sepsis?
Dejager, L., Pinheiro, I., Dejonckheere, E., & Libert, C. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.01.001 · Cited by 784
Novel strategies for the treatment of sepsis
Riedemann, N. C., Guo, R.-F., & Ward, P. A. (2003) · Nature Medicine · doi:10.1038/nm0503-517 · Cited by 773
Self-citation
Metadata
- Authors
- Riedemann, N. C., Neff, T. A., Guo, R.-F., Bernacki, K. D., Laudes, I. J., Sarma, J. V., Lambris, J. D., & Ward, P. A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-01-01
- Volume
- 170
- Issue
- 1
- Pages
- 503-507
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1569271652
- Cited by
- 330
- References
- 40
- FWCI
- 14.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.